Prospects of adjuvant RANKL inhibition in breast cancer?

by Rachner, T D, Wimberger, P, Hofbauer, L C
Published 2015

Morbidity of Inguinofemoral Lymphadenectomy in Vulval Cancer

by Soliman, A. A., Heubner, M., Kimmig, R., Wimberger, P.
Published 2012

Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group

by du Bois, A, Vergote, I, Wimberger, P, Ray-Coquard, I, Harter, P, Curtis, L B, Mitrica, I
Published 2012

Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer

by Kuhlmann, J. D., Bankfalvi, A., Schmid, K. W., Callies, R., Kimmig, R., Wimberger, P., Siffert, W., Bachmann, H. S.
Published 2016

Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

by Wimberger, P., Gilet, H., Gonschior, A-K., Heiss, M. M., Moehler, M., Oskay-Oezcelik, G., Al-Batran, S-E., Schmalfeldt, B., Schmittel, A., Schulze, E., Parsons, S. L.
Published 2012

Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study

by Trillsch, F, Mahner, S, Vettorazzi, E, Woelber, L, Reuss, A, Baumann, K, Keyver-Paik, M-D, Canzler, U, Wollschlaeger, K, Forner, D, Pfisterer, J, Schroeder, W, Muenstedt, K, Richter, B, Fotopoulou, C, Schmalfeldt, B, Burges, A, Ewald-Riegler, N, de Gregorio, N, Hilpert, F, Fehm, T, Meier, W, Hillemanns, P, Hanker, L, Hasenburg, A, Strauss, H-G, Hellriegel, M, Wimberger, P, Kommoss, S, Kommoss, F, Hauptmann, S, du Bois, A
Published 2015